A Single-Center, Open-Label, Controlled, Randomized Study to Investigate the Impact of a Sequential Oral Contraceptive (SH T00658ID) as Compared to a Sequential Oral Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D00264A) on Plasma Lipids, Hemostatic Variables, and Carbohydrate Metabolism in Healthy Female Volunteers Aged 18-50 Years Over 7 Treatment Cycles, Including the Pharmacokinetics.
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2011
At a glance
- Drugs Estradiol valerate/dienogest; Ethinylestradiol/levonorgestrel
- Indications Pregnancy
- Focus Pharmacodynamics
- 01 Aug 2011 Results published in Clinical Drug Investigation.
- 12 May 2009 Planned patient number (58) added as reported by ClinicalTrials.gov.
- 12 May 2009 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.